Page last updated: 2024-10-25

clofibrate and Alcoholic Liver Diseases

clofibrate has been researched along with Alcoholic Liver Diseases in 1 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Research Excerpts

ExcerptRelevanceReference
"Treatment with clofibrate, a PPARalpha-activating ligand, led to a marked decrease in fatty liver and complete abrogation of necroinflammatory changes in FE rats."1.32Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. ( Bass, NM; Dannenberg, AJ; Jokelainen, K; Nanji, AA, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nanji, AA1
Dannenberg, AJ1
Jokelainen, K1
Bass, NM1

Other Studies

1 other study available for clofibrate and Alcoholic Liver Diseases

ArticleYear
Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:1

    Topics: Acyl-CoA Oxidase; Animals; Carrier Proteins; Clofibrate; Cyclooxygenase 2; Ethanol; Fatty Acid-Bindi

2004